Table 1.
Baseline characteristics of patients on dialysis and patients with transplants
| Characteristic | Dialysis, n (%) | Transplantation, n (%) |
|---|---|---|
| Total | 52,936 (100) | 16,820 (100) |
| Sex | ||
| Men | 31,224 (59.0) | 10,172 (60.5) |
| Women | 21,712 (41.0) | 6648 (39.5) |
| Age at reaching ESRD, yr | ||
| Under 20 | 1436 (2.7) | 1514 (9.0) |
| 20–34 | 4530 (8.6) | 3770 (22.4) |
| 35–49 | 9688 (18.3) | 5794 (34.5) |
| 50–64 | 16,778 (31.7) | 5205 (31.0) |
| 65 or over | 20,504 (38.7) | 537 (3.2) |
| Ethnicity | ||
| White | 42,234 (79.8) | 14,255 (84.8) |
| Indigenous | 4222 (8.0) | 563 (3.4) |
| Other | 6480 (12.2) | 2002 (11.9) |
| Cause of renal failure | ||
| GN | 14,549 (27.5) | 7331 (43.6) |
| Vascular | 6556 (12.4) | 715 (4.3) |
| Polycystic kidney disease | 3480 (6.6) | 2110 (12.5) |
| Reflux | 2047 (3.9) | 1610 (9.6) |
| Diabetes mellitus | 13,918 (26.3) | 1856 (11.0) |
| Other | 12,386 (23.4) | 3198 (19.0) |
| Comorbidities | ||
| Chronic lung disease | 8045 (16.7) | 1405 (9.3) |
| Coronary artery disease | 20,194 (41.8) | 3220 (21.4) |
| Peripheral vascular disease | 12,389 (25.7) | 1766 (11.7) |
| Cerebrovascular disease | 7836 (16.3) | 1199 (8.0) |
| Diabetes mellitus | 20,549 (42.0) | 4025 (26.1) |
| Preexisting cancer | 5762 (10.9) | 717 (4.3) |
| Smoker (current or former) | 24,444 (52.2) | 5659 (40.8) |
| Initial renal replacement modality | ||
| Hemodialysis | 37,767 (71.3) | 10,738 (63.8) |
| Peritoneal dialysis | 15,169 (28.7) | 4586 (27.3) |
| Transplantation | — | 1496 (8.9) |
| Initial immunosuppression | ||
| Prednisolone | — | 15,653 (94.8) |
| Tacrolimus | — | 6438 (39.0) |
| Cyclosporin | — | 8969 (54.3) |
| Mycophenolate | — | 8242 (49.9) |
| Azathioprine | — | 5576 (33.8) |
—, not applicable.